These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 552672)

  • 1. Comparative efficacy of drugs in bovine anaplasmosis.
    Mishra AK; Sharma NN
    Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina.
    Sarli M; Novoa MB; Mazzucco MN; Morel N; Primo ME; de Echaide ST; Echaide IE
    Vet Parasitol Reg Stud Reports; 2021 Jan; 23():100513. PubMed ID: 33678368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of various chemotherapeutic agents in experimental bovine anaplasmosis.
    Sharma SK; Banerjee DP; Gautam OP
    Ann Rech Vet; 1977; 8(3):307-13. PubMed ID: 606144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidocarb dipropionate in the treatment of Anaplasma marginale in cattle: Effects on enzymes of the antioxidant, cholinergic, and adenosinergic systems.
    Doyle RL; Fritzen A; Bottari NB; Alves MS; da Silva AD; Morsch VM; Schetinger MR; Martins JR; Santos JS; Machado G; da Silva AS
    Microb Pathog; 2016 Aug; 97():226-30. PubMed ID: 27301742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of acute bovine anaplasmosis.
    Wilson AJ; Parker R; Parker M; Hall WT; Trueman KF
    Aust Vet J; 1979 Feb; 55(2):71-3. PubMed ID: 444164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride.
    McHardy N; Berger J; Taylor RJ; Farebrother D; James JA
    Res Vet Sci; 1980 Sep; 29(2):198-202. PubMed ID: 6451008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of imidocarb prophylaxis on the pathogenicity and immunogenicity of Anaplasma marginale infections in cattle.
    de Vos AJ; McGregor W; Stewart NP; Dalgliesh RJ; Barry DN
    Aust Vet J; 1987 Mar; 64(3):83-5. PubMed ID: 3579755
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to anaplasmosis after elimination of latent Anaplasma marginale infections.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):169-70. PubMed ID: 557302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of the carrier state of bovine anaplasmosis with imidocarb.
    Roby TO; Mazzola V
    Am J Vet Res; 1972 Oct; 33(10):1931-3. PubMed ID: 5074698
    [No Abstract]   [Full Text] [Related]  

  • 17. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle.
    Coetzee JF; Apley MD; Kocan KM; Rurangirwa FR; Van Donkersgoed J
    Vet Parasitol; 2005 Jan; 127(1):61-73. PubMed ID: 15675047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidocarb dipropionate therapy in Kenyan anaplasmosis and babesiosis.
    McHardy N; Simpson RM
    Trop Anim Health Prod; 1974 May; 6(2):63-70. PubMed ID: 4413774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.